Cellivery Therapeutics, Inc.
Records under this name other than the patents Cellivery Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.
Showing 1 to 4 of 4 · Back to Cellivery Therapeutics, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,319,546 | Cell-Permeable (CP)-CAS9 Recombinant Protein and Uses Thereof Lapsed on the fee record Ended May 3, 2026 · High confidence | Lapsed on the fee record | Ended May 3, 2026 | High confidence |
| US 11,279,743 | Cell-Permeable Bone Morphogenetic Protein (CPBMP) Recombinant Protein and Use Thereof Lapsed on the fee record Ended Mar 22, 2026 · High confidence | Lapsed on the fee record | Ended Mar 22, 2026 | High confidence |
| US 10,975,132 | Cell-Permeable (ICP)-SOCS3 Recombinant Protein and Uses Thereof Lapsed on the fee record Ended Apr 13, 2025 · High confidence | Lapsed on the fee record | Ended Apr 13, 2025 | High confidence |
| US 10,961,292 | Cell-Permeable (ICP)-SOCS3 Recombinant Protein and Uses Thereof Lapsed on the fee record Ended Mar 30, 2025 · High confidence | Lapsed on the fee record | Ended Mar 30, 2025 | High confidence |